| Primary |
| Depression |
37.7% |
| Product Used For Unknown Indication |
33.8% |
| Drug Use For Unknown Indication |
13.5% |
| Major Depression |
2.5% |
| Anxiety |
2.3% |
| Bipolar Disorder |
2.0% |
| Smoking Cessation Therapy |
2.0% |
| Attention Deficit/hyperactivity Disorder |
1.3% |
| Insomnia |
0.7% |
| Chronic Obstructive Pulmonary Disease |
0.6% |
| Ex-tobacco User |
0.6% |
| Blood Pressure Increased |
0.5% |
| Blood Cholesterol Increased |
0.5% |
| Affective Disorder |
0.3% |
| Seasonal Affective Disorder |
0.3% |
| Sleep Disorder |
0.3% |
| Blood Pressure |
0.3% |
| Diabetes Mellitus |
0.3% |
| Disturbance In Attention |
0.3% |
| Hepatitis C |
0.3% |
|
| Drug Ineffective |
29.0% |
| Completed Suicide |
13.3% |
| Suicidal Ideation |
5.3% |
| Poisoning |
3.9% |
| Tremor |
3.9% |
| Vomiting |
3.7% |
| Malaise |
3.6% |
| Overdose |
3.4% |
| Depression |
3.2% |
| Weight Increased |
3.2% |
| Feeling Abnormal |
3.1% |
| Therapeutic Response Decreased |
3.1% |
| Convulsion |
2.9% |
| Insomnia |
2.9% |
| Product Quality Issue |
2.9% |
| Nausea |
2.8% |
| Pharmaceutical Product Complaint |
2.6% |
| Headache |
2.4% |
| Weight Decreased |
2.4% |
| Adverse Drug Reaction |
2.3% |
|
| Secondary |
| Product Used For Unknown Indication |
35.4% |
| Depression |
20.1% |
| Drug Use For Unknown Indication |
20.1% |
| Hypertension |
4.0% |
| Bipolar Disorder |
3.7% |
| Anxiety |
2.0% |
| Smoking Cessation Therapy |
2.0% |
| Hiv Infection |
1.6% |
| Muscle Spasms |
1.6% |
| Pain |
1.4% |
| Suicide Attempt |
1.2% |
| Migraine |
1.0% |
| Blood Pressure |
0.8% |
| Bipolar I Disorder |
0.7% |
| Bipolar Ii Disorder |
0.7% |
| Depressive Symptom |
0.7% |
| Multiple Allergies |
0.7% |
| Dyspepsia |
0.7% |
| Hypersensitivity |
0.7% |
| Insomnia |
0.7% |
|
| Completed Suicide |
13.5% |
| Death |
9.1% |
| Suicidal Ideation |
9.1% |
| Overdose |
7.7% |
| Toxicity To Various Agents |
7.7% |
| Cardio-respiratory Arrest |
6.7% |
| Tremor |
4.8% |
| Vomiting |
4.8% |
| Suicide Attempt |
4.3% |
| Vestibular Disorder |
4.3% |
| Drug Ineffective |
3.8% |
| Depression |
3.4% |
| Drug Interaction |
2.9% |
| Sleep Disorder |
2.9% |
| Weight Increased |
2.9% |
| Insomnia |
2.4% |
| Memory Impairment |
2.4% |
| Rash |
2.4% |
| Respiratory Arrest |
2.4% |
| Transaminases Increased |
2.4% |
|
| Concomitant |
| Product Used For Unknown Indication |
19.6% |
| Depression |
16.0% |
| Drug Use For Unknown Indication |
9.0% |
| Pain |
8.1% |
| Anxiety |
6.6% |
| Hypertension |
5.6% |
| Contraception |
3.5% |
| Bipolar Disorder |
3.2% |
| Insomnia |
3.0% |
| Rheumatoid Arthritis |
2.8% |
| Nausea |
2.7% |
| Migraine |
2.4% |
| Gastrooesophageal Reflux Disease |
2.4% |
| Hypersensitivity |
2.3% |
| Uveitis |
2.3% |
| Osteoporosis |
2.1% |
| Asthma |
2.1% |
| Blood Cholesterol Increased |
2.1% |
| Hepatitis C |
2.1% |
| Premenstrual Syndrome |
2.1% |
|
| Vomiting |
10.6% |
| Weight Decreased |
8.4% |
| Pain |
7.7% |
| Pulmonary Embolism |
7.0% |
| Weight Increased |
6.6% |
| Nausea |
5.9% |
| Drug Ineffective |
5.5% |
| Wrong Technique In Drug Usage Process |
5.5% |
| Myocardial Infarction |
4.8% |
| Suicidal Ideation |
4.4% |
| Ventricular Septal Defect |
4.4% |
| Cholecystitis Chronic |
4.0% |
| Gallbladder Disorder |
4.0% |
| Cholelithiasis |
3.3% |
| Wound Drainage |
3.3% |
| Convulsion |
2.9% |
| Depression |
2.9% |
| Somnolence |
2.9% |
| Toxicity To Various Agents |
2.9% |
| White Blood Cell Count Decreased |
2.9% |
|
| Interacting |
| Depression |
16.8% |
| Diabetes Mellitus |
15.0% |
| Drug Use For Unknown Indication |
11.2% |
| Tachyarrhythmia |
7.5% |
| Bipolar Disorder |
6.5% |
| Hiv Infection |
5.6% |
| Antidepressant Therapy |
3.7% |
| Blood Cholesterol Increased |
3.7% |
| Dyslipidaemia |
3.7% |
| Fibromyalgia |
3.7% |
| High Density Lipoprotein Decreased |
3.7% |
| Obsessive-compulsive Disorder |
3.7% |
| Anaemia |
1.9% |
| Arthritis |
1.9% |
| Basedow's Disease |
1.9% |
| Blood Potassium |
1.9% |
| Ex-tobacco User |
1.9% |
| Fluid Retention |
1.9% |
| Gastrooesophageal Reflux Disease |
1.9% |
| Multiple Allergies |
1.9% |
|
| Drug Interaction |
40.0% |
| Myocardial Infarction |
20.0% |
| Throat Irritation |
10.0% |
| Convulsive Threshold Lowered |
5.0% |
| Hallucination, Auditory |
5.0% |
| Memory Impairment |
5.0% |
| Muscle Spasms |
5.0% |
| Nonspecific Reaction |
5.0% |
| Pain |
5.0% |
|
